|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, UC San Diego, San Diego, California, United States
2 Medicine, UC San Diego, San Diego, California, United States; Department of Medicine, University of California, La Jolla, California, United States
* To whom correspondence should be addressed. E-mail: dbelke{at}ucsd.edu.
While several transgenic mouse models exhibit improved contractile characteristics in the heart, less is known about how these changes influence energy metabolism, specifically the balance between carbohydrate and fatty acid oxidation. In the present study we examine glucose and fatty acid oxidation in transgenic mice generated to overexpress SERCA which have an enhanced contractile phenotype. Energy substrate metabolism was measured in isolated working hearts using radiolabelled glucose and palmitate. We also examined oxygen consumption to see if SERCA overexpression is associated with increased oxygen utilization. Since SERCA is important in calcium handling within the cardiac myocyte we examined cytosolic calcium transients in isolated myocytes using indo-1 and mitochondrial calcium levels using Pericam, an adenovirally-expressed mitochondrially-targeted ratiometric calcium indicator. Oxygen consumption did not differ between WT and SERCA groups; however, we were able to show an increased utilization of glucose for oxidative metabolism and a corresponding decreased utilization of fatty acids in the SERCA group. Cytosolic calcium transients were increased in myocytes isolated from SERCA mice and they show a faster rate of decay of the calcium transient. Accompanying these observations we noted increased levels of mitochondrial calcium in the SERCA group which was associated with an increase in the active form of the pyruvate dehydrogenase complex. As an increase in mitochondrial calcium levels leads to activation of the pyruvate dehydrogenase complex (the rate limiting step for carbohydrate oxidation), the increased glucose utilization observed in isolated perfused hearts in the SERCA group may reflect a higher level of mitochondrial calcium.
This article has been cited by other articles:
![]() |
Y. Hu, J. Suarez, E. Fricovsky, H. Wang, B. T. Scott, S. A. Trauger, W. Han, Y. Hu, M. O. Oyeleye, and W. H. Dillmann Increased Enzymatic O-GlcNAcylation of Mitochondrial Proteins Impairs Mitochondrial Function in Cardiac Myocytes Exposed to High Glucose J. Biol. Chem., January 2, 2009; 284(1): 547 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suarez, Y. Hu, A. Makino, E. Fricovsky, H. Wang, and W. H. Dillmann Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1561 - C1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. O'Donnell, A. Fields, X. Xu, S. A. K. Chowdhury, D. L. Geenen, and J. Bi Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2483 - H2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suarez, B. Scott, and W. H. Dillmann Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1439 - R1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Broderick, L. Alvarez, M. Balasubramanian, D. D. Belke, A. Makino, A. Chan, V. L. Woods Jr., W. H. Dillmann, V. S. Sharma, R. B. Pilz, et al. Nitrosyl-Cobinamide, a New and Direct Nitric Oxide Releasing Drug Effective In Vivo Experimental Biology and Medicine, December 1, 2007; 232(11): 1432 - 1440. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |